Cargando…
Metabolism in Cancer Stem Cells: Targets for Clinical Treatment
Cancer stem cells (CSCs) have high tumorigenicity, high metastasis and high resistance to treatment. They are the key factors for the growth, metastasis and drug resistance of malignant tumors, and are also the important reason for the occurrence and recurrence of tumors. Metabolic reprogramming ref...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736883/ https://www.ncbi.nlm.nih.gov/pubmed/36497050 http://dx.doi.org/10.3390/cells11233790 |
_version_ | 1784847145515352064 |
---|---|
author | Wen, Gui-Min Xu, Xiao-Yan Xia, Pu |
author_facet | Wen, Gui-Min Xu, Xiao-Yan Xia, Pu |
author_sort | Wen, Gui-Min |
collection | PubMed |
description | Cancer stem cells (CSCs) have high tumorigenicity, high metastasis and high resistance to treatment. They are the key factors for the growth, metastasis and drug resistance of malignant tumors, and are also the important reason for the occurrence and recurrence of tumors. Metabolic reprogramming refers to the metabolic changes that occur when tumor cells provide sufficient energy and nutrients for themselves. Metabolic reprogramming plays an important role in regulating the growth and activity of cancer cells and cancer stem cells. In addition, the immune cells or stromal cells in the tumor microenvironment (TME) will change due to the metabolic reprogramming of cancer cells. Summarizing the characteristics and molecular mechanisms of metabolic reprogramming of cancer stem cells will provide new ideas for the comprehensive treatment of malignant tumors. In this review, we summarized the changes of the main metabolic pathways in cancer cells and cancer stem cells. |
format | Online Article Text |
id | pubmed-9736883 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97368832022-12-11 Metabolism in Cancer Stem Cells: Targets for Clinical Treatment Wen, Gui-Min Xu, Xiao-Yan Xia, Pu Cells Review Cancer stem cells (CSCs) have high tumorigenicity, high metastasis and high resistance to treatment. They are the key factors for the growth, metastasis and drug resistance of malignant tumors, and are also the important reason for the occurrence and recurrence of tumors. Metabolic reprogramming refers to the metabolic changes that occur when tumor cells provide sufficient energy and nutrients for themselves. Metabolic reprogramming plays an important role in regulating the growth and activity of cancer cells and cancer stem cells. In addition, the immune cells or stromal cells in the tumor microenvironment (TME) will change due to the metabolic reprogramming of cancer cells. Summarizing the characteristics and molecular mechanisms of metabolic reprogramming of cancer stem cells will provide new ideas for the comprehensive treatment of malignant tumors. In this review, we summarized the changes of the main metabolic pathways in cancer cells and cancer stem cells. MDPI 2022-11-26 /pmc/articles/PMC9736883/ /pubmed/36497050 http://dx.doi.org/10.3390/cells11233790 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Wen, Gui-Min Xu, Xiao-Yan Xia, Pu Metabolism in Cancer Stem Cells: Targets for Clinical Treatment |
title | Metabolism in Cancer Stem Cells: Targets for Clinical Treatment |
title_full | Metabolism in Cancer Stem Cells: Targets for Clinical Treatment |
title_fullStr | Metabolism in Cancer Stem Cells: Targets for Clinical Treatment |
title_full_unstemmed | Metabolism in Cancer Stem Cells: Targets for Clinical Treatment |
title_short | Metabolism in Cancer Stem Cells: Targets for Clinical Treatment |
title_sort | metabolism in cancer stem cells: targets for clinical treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736883/ https://www.ncbi.nlm.nih.gov/pubmed/36497050 http://dx.doi.org/10.3390/cells11233790 |
work_keys_str_mv | AT wenguimin metabolismincancerstemcellstargetsforclinicaltreatment AT xuxiaoyan metabolismincancerstemcellstargetsforclinicaltreatment AT xiapu metabolismincancerstemcellstargetsforclinicaltreatment |